Related Experiment Video
Updated: Oct 11, 2025

09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
8.8K
Challenges for assessing replicability in preclinical cancer biology
Timothy M Errington1, Alexandria Denis1, Nicole Perfito2
1Center for Open Science, Charlottesville, United States.
Elife
|December 7, 2021
Summary
Replicating cancer biology research proved difficult due to insufficient data, poor experimental detail, and protocol modifications. These challenges highlight concerns about the credibility of preclinical findings.
Area of Science:
- Biomedical Research
- Cancer Biology
- Scientific Reproducibility
Background:
- The Reproducibility Project: Cancer Biology aimed to assess the replicability of preclinical cancer research.
- The project initially planned to repeat 193 experiments from 53 high-impact publications.
Purpose of the Study:
- To identify and report the barriers and challenges encountered during the replication of cancer biology experiments.
- To evaluate the feasibility of repeating published preclinical cancer research.
Main Methods:
- Attempted to repeat 193 experiments from 53 cancer biology papers, with peer-reviewed protocols and data analysis plans.
- Documented issues related to statistical reporting, experimental detail, author communication, and protocol modifications.
Main Results:
- Only 50 experiments from 23 papers were successfully repeated due to significant challenges.
- Key statistics were publicly available for only 4 experiments; author assistance was inconsistent (helpful for 41%, unhelpful/unresponsive for 32%).
- 67% of protocols required modifications, with only 41% of those modifications being implementable.
Conclusions:
- Replicating preclinical cancer biology research faces substantial obstacles, including lack of detailed methodology and statistical data.
- Inconsistent author support and necessary protocol adaptations further impede replication efforts.
- The difficulties encountered raise fundamental questions about the credibility and reliability of published scientific findings in cancer biology.

